FE Today Logo

GP, GSK Q1 earnings slide

Twelve cos disclose financial reports for Jan-Mar quarter

FE Report | April 23, 2018 00:00:00

Some 12 more listed companies, including the largest-market cap company Grameenphone (GP), disclosed un-audited financial reports for the January-March quarter of 2018 on Sunday.

Of them, the earnings per share (EPS) of seven companies, including GP and GlaxoSmithKline Bangladesh, declined while five companies' earnings increased in the quarter compared to the same quarter of the previous year.

Grameenphone's net profit fell slightly by 2.50 per cent year-on-year to Tk 6.39 billion in the January-March quarter of 2018, according to the company's financial statement posted on its website.

GP's earnings per share (EPS) declined to Tk 4.74 in January-March quarter from Tk 4.86 in the same period a year ago, according to the financial statement.

The net operating cash flow per share (NOCFPS) was Tk 11.60 for January-March 2018 as against Tk 12.04 for January-March 2017.

The net asset value (NAV) per share was Tk 32.73 as on March 31, 2018 and Tk. 29.72 as on March 31, 2017.

Grameenphone, the largest mobile phone operator in Bangladesh, has not made any official comment on the report yet.

Following the news, the GP's share price fell 2.42 per cent or Tk 12 each to close at Tk 484.10 on Sunday.

However, Grameenphone Ltd. reported revenue of Tk 31.2 billion for the first quarter of 2018, a 2.0 per cent growth from the same period last year. Data revenue grew by 23.9 per cent along with voice revenue growth of 3.9 per cent, according to a statement issued on Sunday.

Michael Patrick Foley, CEO of Grameenphone Ltd. said, "The quarter also marked healthy topline and subscriber growth amidst the ongoing competitive environment. We launched a couple of relevant market offers both in voice and data that is showing positive results in revenue generating base and its corresponding usage."

Karl Erik Broten, CFO of Grameenphone Ltd. said, "Our investments in consolidated superior network experience and market offers will drive growth going forward."

Meanwhile, GlaxoSmithKline (GSK) Bangladesh's earnings per share fell 21.62 per cent year-on-year to Tk 11.49 for January-March, 2018. In January-March period of 2017, its EPS was Tk 14.66.

The world's leading research-based pharmaceutical and healthcare company's share price also declined by 0.83 per cent to close at Tk 1,456.70 each at DSE on Sunday.

The EPS of Mozaffar Hossain Spinning Mills, Fine Foods, National Tea Company, Hakkani Pulp & Paper Mills, and Bangladesh Submarine Cable Company Limited also declined.

On the other hand, the EPS of Rahima Food Corporation, Padma Oil Company, HR Textile, BBS Cables and Delta Brac Housing Finance Corporation increased in January-March quarter, 2018.

[email protected]

Share if you like